اطلاعات داروی نمایش داده شده مستقیما از دیتابیس اطلاعات دارویی سازمان غذا و دارو آمریکا (FDA)  استخراج می شود و مرتبا به روز رسانی می شود
داروی نمایش داده شده مورد تایید FDA  می باشد و اطلاعات ثبت آن در زیر قابل مشاهده است
BEPREVE از شرکت BAUSCH AND LOMB INC
   New Drug Application (NDA): 022288
    
Company: BAUSCH AND LOMB INC                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                 
| Drug Name | Active Ingredients | Strength | Dosage Form/Route | Marketing Status | TE Code | RLD | RS | 
|---|---|---|---|---|---|---|---|
| BEPREVE | BEPOTASTINE BESILATE | 1.5% | SOLUTION/DROPS;OPHTHALMIC | Prescription | 
 AT  | 
Yes | Yes | 
Original Approvals or Tentative Approvals
| Action Date | Submission | Action Type | Submission Classification | Review Priority; Orphan Status | Letters, Reviews, Labels, Patient Package Insert | Notes | Url | 
|---|---|---|---|---|---|---|---|
| 09/08/2009 | ORIG-1 | Approval | 
 Type 1 – New Molecular Entity  | 
 STANDARD  | 
 
  | 
         https://www.accessdata.fda.gov/drugsatfda_docs/label/2009/022288lbl.pdf  | 
Supplements
| Action Date | Submission | Supplement Categories or Approval Type | Letters, Reviews, Labels, Patient Package Insert | Note | Url | 
|---|---|---|---|---|---|
| 02/09/2018 | SUPPL-8 | Labeling-Package Insert | 
 https://www.accessdata.fda.gov/drugsatfda_docs/label/2018/022288s008lbl.pdf https://www.accessdata.fda.gov/drugsatfda_docs/appletter/2018/022288Orig1s008ltr.pdf  | 
||
| 02/05/2016 | SUPPL-5 | Manufacturing (CMC) | 
 Label is not available on this site.  | 
||
| 06/28/2012 | SUPPL-3 | Labeling-Package Insert | 
 https://www.accessdata.fda.gov/drugsatfda_docs/label/2012/022288s003lbl.pdf https://www.accessdata.fda.gov/drugsatfda_docs/appletter/2012/022288s003ltr.pdf  | 
| Action Date | Submission | Supplement Categories or Approval Type | Letters, Reviews, Labels, Patient Package Insert  | 
Note | Url | 
|---|---|---|---|---|---|
| 02/09/2018 | SUPPL-8 | 
 Labeling-Package Insert  | 
Label (PDF) | https://www.accessdata.fda.gov/drugsatfda_docs/label/2018/022288s008lbl.pdf | |
| 06/28/2012 | SUPPL-3 | 
 Labeling-Package Insert  | 
Label (PDF) | https://www.accessdata.fda.gov/drugsatfda_docs/label/2012/022288s003lbl.pdf | |
| 09/08/2009 | ORIG-1 | Approval | Label (PDF) | https://www.accessdata.fda.gov/drugsatfda_docs/label/2009/022288lbl.pdf | 
BEPREVE
SOLUTION/DROPS;OPHTHALMIC; 1.5%
TE Code = AT
| Drug Name | Active Ingredients | Strength | Dosage Form/Route | Marketing Status | RLD | TE Code | Application No. | Company | 
|---|---|---|---|---|---|---|---|---|
| BEPOTASTINE BESILATE | BEPOTASTINE BESILATE | 1.5% | SOLUTION/DROPS;OPHTHALMIC | Prescription | No | AT | 206066 | APOTEX | 
| BEPOTASTINE BESILATE | BEPOTASTINE BESILATE | 1.5% | SOLUTION/DROPS;OPHTHALMIC | Prescription | No | AT | 206220 | MYLAN | 
| BEPREVE | BEPOTASTINE BESILATE | 1.5% | SOLUTION/DROPS;OPHTHALMIC | Prescription | Yes | AT | 022288 | BAUSCH AND LOMB INC | 
                
                  
                                                
                                                
                                                
                                                
                                                
                                                
                                                
                                                
                                                
                                                
                                                
                                                
                                                
                                                
                                                
                                                
نظرات کاربران